CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 242 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $92,044,178 | +22.5% | 3,377,768 | 0.0% | 6.80% | +17.1% |
Q2 2023 | $75,155,338 | +2.7% | 3,377,768 | 0.0% | 5.81% | +20.3% |
Q1 2023 | $73,162,455 | +6.6% | 3,377,768 | 0.0% | 4.83% | +12.7% |
Q4 2022 | $68,602,468 | -19.6% | 3,377,768 | +1.5% | 4.28% | +5.3% |
Q3 2022 | $85,324,000 | +42.0% | 3,327,768 | +31.7% | 4.07% | +37.5% |
Q2 2022 | $60,080,000 | – | 2,526,490 | – | 2.96% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |